BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1372614)

  • 1. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein.
    Sammaritano LR; Gharavi AE; Soberano C; Levy RA; Lockshin MD
    J Clin Immunol; 1992 Jan; 12(1):27-35. PubMed ID: 1372614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human placental anticoagulant protein: isolation and characterization.
    Funakoshi T; Heimark RL; Hendrickson LE; McMullen BA; Fujikawa K
    Biochemistry; 1987 Aug; 26(17):5572-8. PubMed ID: 2960376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; ViganĂ² D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional site of placental anticoagulant protein: essential histidine residue of placental anticoagulant protein.
    Funakoshi T; Abe M; Sakata M; Shoji S; Kubota Y
    Biochem Biophys Res Commun; 1990 Apr; 168(1):125-34. PubMed ID: 2139329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family.
    Tait JF; Gibson D; Fujikawa K
    J Biol Chem; 1989 May; 264(14):7944-9. PubMed ID: 2524476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of an anticoagulant protein from human placenta.
    Yoshizaki H; Arai K; Mizoguchi T; Shiratsuchi M; Hattori Y; Nagoya T; Shidara Y; Maki M
    J Biochem; 1989 Feb; 105(2):178-83. PubMed ID: 2524473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of six annexins from human placenta.
    Römisch J; Heimburger N
    Biol Chem Hoppe Seyler; 1990 May; 371(5):383-8. PubMed ID: 2143074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibody and antiphospholipid antibody syndrome.
    Lockshin MD
    Curr Opin Rheumatol; 1991 Oct; 3(5):797-802. PubMed ID: 1836343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional effects of anticardiolipin antibodies.
    Harris EN; Pierangeli SS
    Lupus; 1996 Oct; 5(5):372-7. PubMed ID: 8902763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.
    Gharavi AE; Sammaritano LR; Wen J; Miyawaki N; Morse JH; Zarrabi MH; Lockshin MD
    J Rheumatol; 1994 Jan; 21(1):94-9. PubMed ID: 8151598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family.
    Tait JF; Sakata M; McMullen BA; Miao CH; Funakoshi T; Hendrickson LE; Fujikawa K
    Biochemistry; 1988 Aug; 27(17):6268-76. PubMed ID: 2975506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.
    Rand JH; Wu XX; Quinn AS; Chen PP; McCrae KR; Bovill EG; Taatjes DJ
    Am J Pathol; 2003 Sep; 163(3):1193-200. PubMed ID: 12937161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
    Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
    Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-phospholipid antibodies in the mercuric chloride treated brown Norway rat.
    Marriott JB; Qasim F; Oliveira DB
    J Autoimmun; 1994 Aug; 7(4):457-67. PubMed ID: 7980848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-phospholipid antibodies (aPL) and apoptosis: prothrombin-dependent aPL as a paradigm for phospholipid-dependent interactions with apoptotic cells.
    Rauch J; D'Agnillo P; Subang R; Levine JS
    Thromb Res; 2004; 114(5-6):371-82. PubMed ID: 15507267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the relationship between 'antiphospholipid' antibodies and the lupus anticoagulant.
    Exner T; McRea J
    Blood Coagul Fibrinolysis; 1990; 1(1):17-21. PubMed ID: 2129389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity purified human antiphospholipid antibodies bind normal term placenta.
    Donohoe S; Kingdom JC; Mackie IJ
    Lupus; 1999; 8(7):525-31. PubMed ID: 10483030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of annexins IV and V in relation to antiphospholipid antibody status in women with a history of recurrent miscarriage.
    Ulander VM; Stefanovic V; Masuda J; Suzuki K; Hiilesmaa V; Kaaja R
    Thromb Res; 2007; 120(6):865-70. PubMed ID: 17363042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid cofactor.
    Gharavi AE
    Stroke; 1992 Feb; 23(2 Suppl):I7-10. PubMed ID: 1561674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.